309 related articles for article (PubMed ID: 12759391)
21. Homeobox gene CDX2 inhibits human pancreatic cancer cell proliferation by down-regulating cyclin D1 transcriptional activity.
Takahashi K; Hirano F; Matsumoto K; Aso K; Haneda M
Pancreas; 2009 Jan; 38(1):49-57. PubMed ID: 19106744
[TBL] [Abstract][Full Text] [Related]
22. Critical role of lysophospholipids in the pathophysiology, diagnosis, and management of ovarian cancer.
Mills GB; Eder A; Fang X; Hasegawa Y; Mao M; Lu Y; Tanyi J; Tabassam FH; Wiener J; Lapushin R; Yu S; Parrott JA; Compton T; Tribley W; Fishman D; Stack MS; Gaudette D; Jaffe R; Furui T; Aoki J; Erickson JR
Cancer Treat Res; 2002; 107():259-83. PubMed ID: 11775454
[TBL] [Abstract][Full Text] [Related]
23. Constitutive and lysophosphatidic acid (LPA)-induced LPA production: role of phospholipase D and phospholipase A2.
Eder AM; Sasagawa T; Mao M; Aoki J; Mills GB
Clin Cancer Res; 2000 Jun; 6(6):2482-91. PubMed ID: 10873103
[TBL] [Abstract][Full Text] [Related]
24. Down-regulation of cyclin D1 expression by prostaglandin A(2) is mediated by enhanced cyclin D1 mRNA turnover.
Lin S; Wang W; Wilson GM; Yang X; Brewer G; Holbrook NJ; Gorospe M
Mol Cell Biol; 2000 Nov; 20(21):7903-13. PubMed ID: 11027261
[TBL] [Abstract][Full Text] [Related]
25. Lysophosphatidic acid up-regulates expression of interleukin-8 and -6 in granulosa-lutein cells through its receptors and nuclear factor-kappaB dependent pathways: implications for angiogenesis of corpus luteum and ovarian hyperstimulation syndrome.
Chen SU; Chou CH; Lee H; Ho CH; Lin CW; Yang YS
J Clin Endocrinol Metab; 2008 Mar; 93(3):935-43. PubMed ID: 18171700
[TBL] [Abstract][Full Text] [Related]
26. Induction of macrophage migration inhibitory factor by lysophosphatidic acid: relevance to tumor growth and angiogenesis.
Sun B; Nishihira J; Suzuki M; Fukushima N; Ishibashi T; Kondo M; Sato Y; Todo S
Int J Mol Med; 2003 Oct; 12(4):633-41. PubMed ID: 12964047
[TBL] [Abstract][Full Text] [Related]
27. Lysophospholipid growth factors in the initiation, progression, metastases, and management of ovarian cancer.
Fang X; Gaudette D; Furui T; Mao M; Estrella V; Eder A; Pustilnik T; Sasagawa T; Lapushin R; Yu S; Jaffe RB; Wiener JR; Erickson JR; Mills GB
Ann N Y Acad Sci; 2000 Apr; 905():188-208. PubMed ID: 10818454
[TBL] [Abstract][Full Text] [Related]
28. Transcriptional and post-transcriptional mechanisms for lysophosphatidic acid-induced cyclooxygenase-2 expression in ovarian cancer cells.
Oyesanya RA; Lee ZP; Wu J; Chen J; Song Y; Mukherjee A; Dent P; Kordula T; Zhou H; Fang X
FASEB J; 2008 Aug; 22(8):2639-51. PubMed ID: 18362203
[TBL] [Abstract][Full Text] [Related]
29. Lysophosphatidic acid (LPA) receptors are activated differentially by biological fluids: possible role of LPA-binding proteins in activation of LPA receptors.
Hama K; Bandoh K; Kakehi Y; Aoki J; Arai H
FEBS Lett; 2002 Jul; 523(1-3):187-92. PubMed ID: 12123830
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms for lysophosphatidic acid-induced cytokine production in ovarian cancer cells.
Fang X; Yu S; Bast RC; Liu S; Xu HJ; Hu SX; LaPushin R; Claret FX; Aggarwal BB; Lu Y; Mills GB
J Biol Chem; 2004 Mar; 279(10):9653-61. PubMed ID: 14670967
[TBL] [Abstract][Full Text] [Related]
31. Distinctive expression and functions of the type 4 endothelial differentiation gene-encoded G protein-coupled receptor for lysophosphatidic acid in ovarian cancer.
Goetzl EJ; Dolezalova H; Kong Y; Hu YL; Jaffe RB; Kalli KR; Conover CA
Cancer Res; 1999 Oct; 59(20):5370-5. PubMed ID: 10537322
[TBL] [Abstract][Full Text] [Related]
32. Adenosine triphosphate activates mitogen-activated protein kinase in pre-neoplastic and neoplastic ovarian surface epithelial cells.
Choi KC; Tai CJ; Tzeng CR; Auersperg N; Leung PC
Biol Reprod; 2003 Jan; 68(1):309-15. PubMed ID: 12493727
[TBL] [Abstract][Full Text] [Related]
33. Lysophosphatidic Acid Up-Regulates Hexokinase II and Glycolysis to Promote Proliferation of Ovarian Cancer Cells.
Mukherjee A; Ma Y; Yuan F; Gong Y; Fang Z; Mohamed EM; Berrios E; Shao H; Fang X
Neoplasia; 2015 Sep; 17(9):723-734. PubMed ID: 26476080
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of edg-2/vzg-1 induces apoptosis and anoikis in ovarian cancer cells in a lysophosphatidic acid-independent manner.
Furui T; LaPushin R; Mao M; Khan H; Watt SR; Watt MA; Lu Y; Fang X; Tsutsui S; Siddik ZH; Bast RC; Mills GB
Clin Cancer Res; 1999 Dec; 5(12):4308-18. PubMed ID: 10632375
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-30c-2* expressed in ovarian cancer cells suppresses growth factor-induced cellular proliferation and downregulates the oncogene BCL9.
Jia W; Eneh JO; Ratnaparkhe S; Altman MK; Murph MM
Mol Cancer Res; 2011 Dec; 9(12):1732-45. PubMed ID: 22024689
[TBL] [Abstract][Full Text] [Related]
36. The Role of Lysophosphatidic Acid Receptors in Ovarian Cancer: A Minireview.
Cui R; Bai H; Cao G; Zhang Z
Crit Rev Eukaryot Gene Expr; 2020; 30(3):265-272. PubMed ID: 32749113
[TBL] [Abstract][Full Text] [Related]
37. Cyclopentenone causes cell cycle arrest and represses cyclin D1 promoter activity in MCF-7 breast cancer cells.
Hsiang CH; Straus DS
Oncogene; 2002 Mar; 21(14):2212-26. PubMed ID: 11948404
[TBL] [Abstract][Full Text] [Related]
38. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K
Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108
[TBL] [Abstract][Full Text] [Related]
39. Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species. Structure-activity relationship of cloned LPA receptors.
Bandoh K; Aoki J; Taira A; Tsujimoto M; Arai H; Inoue K
FEBS Lett; 2000 Jul; 478(1-2):159-65. PubMed ID: 10922489
[TBL] [Abstract][Full Text] [Related]
40. Lysophosphatidic acid is a major regulator of growth-regulated oncogene alpha in ovarian cancer.
Lee Z; Swaby RF; Liang Y; Yu S; Liu S; Lu KH; Bast RC; Mills GB; Fang X
Cancer Res; 2006 Mar; 66(5):2740-8. PubMed ID: 16510595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
